Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Keytruda
Keytruda
Asco-GU – Bristol’s renal cancer lead looks to be short-lived
EP Vantage
Mon, 02/11/19 - 08:24 pm
renal cell carcinoma
Merck
Keytruda
Bristol-Myers Squibb
Opdivo
clinical trials
Sutent
FDA promises speedy review on moving Merck's Keytruda up as first-line head and neck cancer therapy
Endpoints
Mon, 02/11/19 - 10:24 am
Merck
Keytruda
FDA
head and neck cancer
priority review
The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trials
Yahoo/Benzinga
Sun, 02/10/19 - 11:08 pm
Motif Biosciences
Iclaprim
Merck
Keytruda
melanoma
JNJ
esketamine
ASCO
Pfizer
Veru. earnings
Aveo Pharmaceuticals
Calithera Biosciences
Forget Bristol-Myers: Regeneron takes on Merck for the heavyweight title in non-small cell lung cancer
Endpoints
Fri, 02/8/19 - 11:40 am
Regeneron
Merck
Bristol-Myers Squibb
PD-1/L1 therapy
Libtayo
Keytruda
Opdivo
non-small cell lung cancer
Mark Your Calendar For These February PDUFA Dates
Yahoo/Benzinga
Sat, 02/2/19 - 12:31 pm
FDA
DWP-450
Evolus
MOTIF BIO PLC/S ADR
Iclaprim
Bausch Health
Duobrii
Merck
Keytruda
Incyte
Novartis
ruxolitinib
Novo Nordisk
N8-GP
Merck analysts to CEO: What’s so great about your pipeline beyond Keytruda?
Fierce Pharma
Fri, 02/1/19 - 12:15 pm
Merck
Keytruda
vaccines
Merck's Keytruda slashes death risk by 31% in esophageal cancer victory
Fierce Pharma
Tue, 01/15/19 - 12:02 am
Merck
Keytruda
esophageal cancer
Merck's Keytruda faces delay in first-line approval decision
Biopharma Dive
Fri, 12/21/18 - 10:39 pm
FDA
Keytruda
Merck
metastatic non-small cell lung cancer
Merck's Keytruda puts heat on Pfizer, Merck KGaA's Bavencio with new Merkel cell OK
Fierce Pharma
Thu, 12/20/18 - 10:12 am
Merck
Keytruda
Pfizer
Merck KGaA
Bavencio
Merkel cell carcinoma
Merck bags adjuvant okay for Keytruda in melanoma
Pharmaforum
Tue, 12/18/18 - 10:13 am
Merck
Europe
Keytruda
melanoma
Merck increased list prices on Keytruda, Gardasil in November
Biopharma Dive
Thu, 11/29/18 - 11:42 pm
Merck
drug pricing
Keytruda
Gardasil
One more shot at slowing Keytruda’s first-line lung cancer domination
EP Vantage
Wed, 11/28/18 - 10:12 am
Keytruda
Merck
Roche
Tecentriq
Avastin
lung cancer
Merck's Keytruda picks up first-in-class survival win in esophageal cancer
Fierce Pharma
Wed, 11/14/18 - 11:55 am
Merck
Keytruda
esophageal cancer
GSK pancreatic cancer drug heads to phase 1 combo with Merck's Keytruda after positive mouse trial
Fierce Biotech
Mon, 11/12/18 - 11:47 pm
GSK
GSK095
Merck
Keytruda
pancreatic cancer
Merck gets FDA okay for Keytruda as liver cancer therapy
Pharmaforum
Mon, 11/12/18 - 09:35 am
Merck
Keytruda
FDA
hepatocellular carcinoma
liver cancer
OncoSec’s defense of weak preliminary Tavo data for PD-1 resistant melanoma can’t stop a rout
Endpoints
Tue, 11/6/18 - 11:52 pm
OncoSec
Merck
Keytruda
Tavo
melanoma
FDA Action Alert: EyePoint Pharma and Merck
BioSpace
Mon, 11/5/18 - 09:59 am
FDA
Eyepoint
Durasert
posterior segment uveitis
Merck
Keytruda
advanced hepatocellular carcinoma
Merck's Keytruda secures broader lung cancer approval
Biopharma Dive
Wed, 10/31/18 - 11:57 am
Merck
Keytruda
squamous non-small cell lung cancer
ESMO: Merck's Keytruda, alone and in combo, makes its case for earlier use in head and neck cancer
Fierce Pharma
Mon, 10/22/18 - 12:15 pm
Merck
head and neck cancer
Keytruda
ESMO18: Merck’s STING agonist lacks bite on its own
Fierce Biotech
Mon, 10/22/18 - 10:45 am
Merck
STING agonists
MK-1454
Keytruda
solid tumors
lymphoma
Pages
« first
‹ previous
…
11
12
13
14
15
16
17
18
19
…
next ›
last »